Alemtuzumab Induction in Islet Transplantation

Clinical trial NCT00175253 · COMPLETED

Trial details

NCT number: NCT00175253
Sponsor: University of Alberta
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2005-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.